Peritoneal Clearances in Hypertensive Capd Patients after Oral Administration of Clonidine, Enaldpril, and Nifedipine

Author:

Favazza Antonio1,Montanaro Domenico1,Messa Piergiorgio1,Antonucci Francesco1,Gropuzzo Maria1,Mioni Giuseppe1

Affiliation:

1. Renal Unit, Ospedale Regionale, Udine, Italy

Abstract

The authors investigated whether the reduction of arterial pressure, induced by the oral administration of clonidine (CLO), enalapril (EN), and nifedipine (NIF), has any effect on peritoneal transport rates. The study was performed in nine hypertensive patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The patients were submitted to administration of CLO, EN, and NIF, each in randomized succession for two weeks, after withdrawal of any hypotensive therapy for eight days (washout period). The nine patients underwent a four-hour dwell exchange using a 2.27 g/dL glucose two-liter bag after washout and after each hypotensive period. The following parameters were analyzed: mean arterial pressure (MAP), performed in the sitting position; net ultrafiltration; effluent/initial dialysate glucose ratio (GL DIDo); peritoneal clearance of K, BUN, creatinine (Cr), phosphate, beta-2 microglobulin (β2), total proteins, and the ratio between B2 and Cr clearance. Moreover, residual renal Cr and B2 clearances were analyzed. The three drugs significantly reduced MAP at a similar rate. The peritoneal transport parameters after CLO were similar to the results in the washout period. On the contrary, after EN and NIF therapy, Crand B2 clearances were significantly increased, and GL DIDo decreased in comparison to the washout period. The other peritoneal transport parameters after EN and NIF were similar to the washout period. Residual renal Cr and B2 clearances after the three drugs were similar to those in the washout. These data suggest that after two weeks of therapy with EN and NIF, glucose, Cr, and B2 peritoneal transports are influenced by these hypotensive drugs irrespective of the effect on the arterial pressure. These observations may have implications for hypotensive drug selection in CAPD hypertensive patients.

Publisher

SAGE Publications

Subject

Nephrology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3